Targeting mast cells restores T cell infiltration and sensitizes sarcomas to PD-L1 inhibition.

被引：0
|
作者：
Panagi, Myrofora [1 ]
Mpekris, Fotios [1 ]
Voutouri, Chrysovalantis [1 ]
Michael, Christina [1 ]
Constantinidou, Anastasia [2 ]
Martin, John D. [3 ]
Stylianopoulos, Triantafyllos [1 ]
机构：
[1] Univ Cyprus, Nicosia, Cyprus
[2] Bank Cyprus Oncol Ctr, Nicosia, Cyprus
[3] Innovat Ctr Nanomed, Tokyo, Japan
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6382
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inhibition of T-cell-mediated immune response via the PD-1/PD-L1 axis in cholangiocarcinoma cells
    Suriyo, Tawit
    Fuangthong, Mayuree
    Artpradit, Charlermchai
    Ungtrakul, Teerapat
    Sricharunrat, Thaniya
    Taha, Fatma
    Satayavivad, Jutamaad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 897
  • [22] Infiltration of CD8+ cytotoxic T-cells and expression of PD-1 and PD-L1 in ovarian clear cell carcinoma
    Fu, Mengdi
    Zhou, Huimei
    Yang, Jiaxin
    Cao, Dongyan
    Yuan, Zhen
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [23] A new PD-L1 antibody H1A causes PD-L1 degradation and sensitizes cancer cells for cytotoxic therapy
    Tu, Xinyi
    Mutter, Robert
    Lou, Zhenkun
    Dong, Haidong
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [24] Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade
    Kepp, Oliver
    Zitvogel, Laurence
    Kroemer, Guido
    ONCOIMMUNOLOGY, 2019, 8 (10):
  • [25] TAZ teases T cells with PD-L1
    Kanai, Ryan
    Lamar, John M.
    GLAND SURGERY, 2019, 8 (04) : 322 - 326
  • [26] Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
    Kammerer-Jacquet, Solene-Florence
    Deleuze, Antoine
    Saout, Judikael
    Mathieu, Romain
    Laguerre, Brigitte
    Verhoest, Gregory
    Dugay, Frederic
    Belaud-Rotureau, Marc-Antoine
    Bensalah, Karim
    Rioux-Leclercq, Nathalie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [27] Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
    Kotanides, Helen
    Li, Yiwen
    Malabunga, Maria
    Carpenito, Carmine
    Eastman, Scott W.
    Shen, Yang
    Wang, George
    Inigo, Ivan
    Surguladze, David
    Pennello, Anthony L.
    Persaud, Krishnadatt
    Hindi, Sagit
    Topper, Michael
    Chen, Xinlei
    Zhang, Yiwei
    Bulaon, Danielle K.
    Bailey, Tim
    Lao, Yanbin
    Han, Bing
    Torgerson, Stacy
    Chin, Darin
    Sonyi, Andreas
    Haidar, Jaafar N.
    Novosiadly, Ruslan D.
    Moxham, Christopher M.
    Plowman, Gregory D.
    Ludwig, Dale L.
    Kalos, Michael
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (10) : 1300 - 1310
  • [28] Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1
    Chui, Noreen Nog-Qin
    Cheu, Jacinth Wing-Sum
    Yuen, Vincent Wai-Hin
    Chiu, David Kung-Chun
    Goh, Chi-Ching
    Lee, Derek
    Zhang, Misty Shuo
    Ng, Irene Oi-Lin
    Wong, Carmen Chak-Lui
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (01) : 178 - 193
  • [29] Targeting ovarian cancer stem cell by Dot1L inhibition.
    Zhang, Yaqi
    Wang, Yinu
    Zhao, Guangyuan
    Matei, Daniela
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 79 - 79
  • [30] Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth
    Le Qin
    Ruocong Zhao
    Dongmei Chen
    Xinru Wei
    Qiting Wu
    Youguo Long
    Zhiwu Jiang
    Yangqiu Li
    Haipeng Wu
    Xuchao Zhang
    Yilong Wu
    Shuzhong Cui
    Wei Wei
    Huihui Yao
    Zixia Liu
    Su Cao
    Yao Yao
    Zhenfeng Zhang
    Peng Li
    Biomarker Research, 8
12345